Work

33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

Year: 2018
Type: article
Abstract: combination therapy was observed on tumor growth, mice survival, and frequency and sites of metastatic lesions. ResultsIHC results show that tumor tissue is enriched with Flower Win, whereas Flower Lose isoforms are present in the stromal tissue surrounding the tumors (Fig- 1b).Results show a significant reduction in volume of TN PDX observed over a period of 45 days (p<0.0001).Further the KM curves reveal that the mice survival (over 120 days) was significantly longer in the Anti-Flower Ab + TAC compared with TAC alone (P<0.0001) and with controls (P<0.0001).Lastly, combination therapy resulted in a significant reduction in metastatic frequency to kidney, liver, lung, brain, axillary and inguinal lymph nodes (P<0.0001). ConclusionsThis preclinical study demonstrated a significant improvement of survival, metastatic events and tumor regression of triple negative patient-derived tumors in mice treated with monoclonal anti-Flower ABs, compared with TAC alone.Preliminary data reveals comparable results with colon and pancreatic PDX tumor models.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W4237901336
FWCI: 3.44
Cites: 172
Cited by: 47
Related to: 10